Pathological Response Predicts Survival after Pancreatectomy following Neoadjuvant FOLFIRINOX for Pancreatic Cancer

SIMPLE SUMMARY: In pancreatic cancer, complete pathologic response (cPR) after neoadjuvant treatment (NAT) has been rarely reported and its clinical course is not well known. Since the introduction of FOLIFIRINOX in clinical practice, the efficacy of chemotherapy has shown a dramatic improvement and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hyun Jeong, Jeong, Hye Jeong, Lim, Soo Yeun, Yoon, So Jeong, Kim, Hongbeom, Han, In Woong, Heo, Jin Seok, Shin, Sang Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818940/
https://www.ncbi.nlm.nih.gov/pubmed/36612289
http://dx.doi.org/10.3390/cancers15010294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818940/
https://www.ncbi.nlm.nih.gov/pubmed/36612289
http://dx.doi.org/10.3390/cancers15010294

Ejemplares similares